| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jason Baum | Chief Scientific Officer | 2025-03-28 | 6,604 | $0.32 | $2.09kSell |
| Christine Granfield | VP Head of Reg AffairsQual | 2025-03-28 | 6,604 | $0.32 | $2.09kSell |
| Augustine Lawlor | Chief Operating Officer | 2025-03-28 | 7,797 | $0.32 | $2.47kSell |
| Christopher Mirabelli | Chairman of the Board | 2025-03-28 | 6,672 | $0.32 | $2.12kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Perceptive Advisors LLC | 14.96% | 8,476,496 | $17.38M | Insider |
| Beigene Ltd | 12.97% | 7,348,437 | $15.06M | Insider |
| Gilead Sciences Inc | 9.39% | 5,319,148 | $10.90M | Institution |
| Gilead Sciences Inc | 9.39% | 5,319,148 | $10.90M | Insider |
| Healthcare Ventures IX LP | 7.32% | 4,144,804 | $8.50M | Insider |
| John W. Littlechild | 4.62% | 2,618,406 | $5.37M | Insider |
| Augustine Lawlor | 3.03% | 1,718,454 | $3.52M | Insider |
| Douglas E. Onsi | 2.72% | 1,542,971 | $3.16M | Insider |
| Lilly Co Eli | 2.61% | 1,479,307 | $3.03M | Insider |
| Christopher Mirabelli | 2.57% | 1,457,739 | $2.99M | Insider |